ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fatigue"

  • Abstract Number: 1285 • ACR Convergence 2023

    PROMIS Symptom Clusters Predict Disease Activity in the First 6 Months in Newly Diagnosed RA Patients Starting MTX Therapy: Data from the Canadian Early Arthritis Cohort

    Susan Bartlett1, Clifton Bingham2, Orit Schieir3, Marie-France Valois4, Gilles Boire5, Louis Bessette6, Janet Pope7, Diane Tin8, Carter Thorne9, Glen Hazlewood10, Carol Hitchon11, Edward Keystone12 and Vivian Bykerk13, 1McGill University, Montreal, QC, Canada, 2Johns Hopkins Medicine, Baltimore, MD, 3McGill University, Montréal, QC, Canada, 4McGill University, Pointe-Claire, QC, Canada, 5Université de Sherbrooke, Sherbrooke, QC, Canada, 6Centre de l'Ostéoporose et de Rhumatologie de Québec, Quebec City, QC, Canada, 7University of Western Ontario, London, ON, Canada, 8Newmarket Rheumatology Consultants, Newmarket, ON, Canada, 9Southlake Regional Health Centre, Newmarket, ON, Canada, 10University of Calgary, Calgary, AB, Canada, 11University of Manitoba, Winnipeg, MB, Canada, 12Keystone Consulting Enterprises Inc., Toronto, ON, Canada, 13Hospital for Special Surgery, New York, NY

    Background/Purpose: We have previously shown that PROMIS-29 physical (pain, fatigue) and emotional (depression, anxiety) symptom clusters can be used to identify 4 distinct early RA…
  • Abstract Number: PP12 • ACR Convergence 2023

    Sjögren’s-Fatigue: Non-Therapeutic Lifestyle Adjustments to Help Manage My Most Problematic Symptom

    Susan Barajas, Sjögren's Foundation, Los Angeles, CA

    Background/Purpose: I was diagnosed with Sjögren's disease in 2015. I sought help from a rheumatologist after experiencing hand pain. I also had dry eyes and…
  • Abstract Number: 1375 • ACR Convergence 2023

    The Relative Burden of Fatigue Is Associated with High TSH/fT4 Ratio in Korean Patients with Primary Sjogren’s Syndrome

    Jee-in Lee1, Se Rim Choi2, You-Jung Ha2, Eun Ha Kang3, Keun-Suh Kim4, Joon Young Hyon5 and Yun Jong Lee6, 1Seoul National University of Bundang Hospital, Seongnam, South Korea, 2Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnamsi, South Korea, 3Seoul National University Bundang Hospital, Seongnam, South Korea, 4Department of Periodontology, Section of Dentistry, Seoul National University Bundang Hospital, Seongnamsi, South Korea, 5Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnamsi, South Korea, 6Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea

    Background/Purpose: To investigate the prevalence of anti-thyroid autoantibodies, abnormal thyroid function, and their clinical impacts in Korean patients with primary Sjögren's syndrome (pSS). Methods: One…
  • Abstract Number: PP16 • ACR Convergence 2023

    Peer Health Coaches Help Scleroderma Patients Cope with Isolation

    Mary Alore1, Yen Chen2 and Susan Murphy3, 1Troy, MI, 2University of Michigan, Ann Arbor, MI, 3University of Michigan, Plymouth, MI

    Background/Purpose: In 2011, I felt extremely isolated with my new diagnosis of diffuse systemic sclerosis and sought support online and in support groups. In addition…
  • Abstract Number: 1381 • ACR Convergence 2023

    Fatigue and Associated Factors in Patients with Primary Sjogren’s Syndrome Compared to Secondary Sjogren’s Syndrome

    Hyeji Jeon, Hyun-Sook Kim and Kyung-Ann Lee, Soonchunhyang University Seoul Hospital, Seoul, South Korea

    Background/Purpose: Fatigue is one of the dominant symptoms of patients with Primary Sjogren's syndrome (pSS). However, whether fatigue is specific to pSS compared to secondary…
  • Abstract Number: 1424 • ACR Convergence 2023

    Early Fatigue Improvement with Guselkumab Associates with Longer Term Disease Control in Patients with Active Psoriatic Arthritis Reporting Substantial Fatigue: Post Hoc Analyses of a Sub-Population of a Phase 3, Randomized, Controlled Trial of Guselkumab in Biologic-Naïve Patients

    Dafna Gladman1, Xenofon Baraliakos2, Michael Starr3, Roberto Ranza4, Emmanouil Rampakakis5, Natalie shiff6, Francois Nantel7, Chenglong Han8, Andrew James Knowles Ostor9 and Philip J. Mease10, 1Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, Department of Medicine, University of Toronto, Toronto, ON, Canada, 2Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 3Division of Rheumatology, McGill University Health Center, Montreal, QC, Canada, 4Rheumatology Unit, Hospital das Clínicas da Universidade Federal de Uberlândia, Uberlândia, Brazil, 5McGill University, Department of Pediatrics / JSS Medical Research, Scientific Affairs, Montreal, QC, Canada, 6Immunology, Janssen Scientific Affairs, LLC / Adjunct, Community Health and Epidemiology, University of Saskatchewan, Horsham, PA, 7Nantel Medsci Consult, Consultant, Montreal, QC, Canada, 8Immunology, Janssen Global Services, LLC, Malvern, PA, 9Cabrini Hospital, Monash University & Emeritus Research / Australian National University, Canberra, Australia, 10Swedish Medical Center/Providence St. Joseph Health and University of Washington School of Medicine, Seattle, WA

    Background/Purpose: Fatigue is commonly reported by PsA patients (pts) and contributes to disease burden. The fully human IL-23p19-subunit inhibitor guselkumab (GUS) induces clinically meaningful and…
  • Abstract Number: 1575 • ACR Convergence 2023

    Takayasu Arteritis Is Associated with Worse Fatigue Than Healthy Controls Which Persists over Time – A Longitudinal Cohort Study

    Darpan Radheshyam Thakare, Upendra Rathore, Kritika Singh, Vikas Agarwal and Durga P Misra, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India

    Background/Purpose: Few studies have assessed patient-reported outcome measures in Takayasu arteritis (TAK), a rare large vessel vasculitis. We prospectively analysed fatigue and fibromyalgia in TAK…
  • Abstract Number: 1630 • ACR Convergence 2023

    Patient-Reported Fatigue Associated with Joint Histopathology in Rheumatoid Arthritis

    Diyu Fisher1, Dana Orange2, Melanie Smith3, Bella Mehta4, Edoardo Spolaore5, Edward DiCarlo3, Dongmei Sun3, Laura Donlin3 and Susan Goodman3, 1Stony Brook Medicine, Port Jefferson Station, NY, 2The Rockefeller University, New York, NY, 3Hospital for Special Surgery, New York, NY, 4Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 5HSS, New York, NY

    Background/Purpose: Fatigue or tiredness is an important symptom for patients with rheumatoid arthritis (RA), yet the factors associated with fatigue are poorly understood and may…
  • Abstract Number: 057 • 2023 Pediatric Rheumatology Symposium

    A “High-Risk” Depression/Fatigue Profile May Be Associated with Stronger Response to a Psychological Treatment for Childhood-Onset Systemic Lupus Erythematosus (cSLE)

    Elizabeth Ross1, khalid abulaban2, Elizabeth Kessler2, Andrea Knight3 and Natoshia Cunningham4, 1Michigan State University College of Human Medicine, Grand Rapids, MI, 2Helen DeVos Children's Hospital, Grand Rapids, MI, 3The Hospital for Sick Children, Toronto, ON, Canada, 4Michigan State University, Grand Rapids, MI

    Background/Purpose: Children with childhood-onset systemic lupus erythematosus (cSLE) experience more severe disease than their adult counterparts, in addition to high rates of clinical depressive symptoms…
  • Abstract Number: 0390 • ACR Convergence 2022

    Persistent Post-Covid Symptoms in Psoriatic Arthritis Patients

    Sonia Pastor Navarro1, Marta Ibáñez Martínez1, Olga Compán Fernández1, Belén Miguel Ibáñez1, Olga Martínez González1, Cristina Hidalgo Calleja1, Ana Isabel Turrión Nieves1, Susana Gómez Castro2 and Carlos Montilla Morales1, 1Hospital Universitario de Salamanca, Salamanca, Spain, 2Hospital Universitario Salamanca, Salamanca, Spain

    Background/Purpose: Symptomatic onset long after recovery from the acute phase of COVID-19 infection has been reported by the population. Currently, it is not known how…
  • Abstract Number: 2189 • ACR Convergence 2022

    Impact of a Fatigue and Energy Management Program for Persons with Systemic Sclerosis (FAME-iSS): A Pilot Study

    Janet Poole1, Deirdre Connolly2, Jessica Salazar3 and Kristine Carandang4, 1University of New Mexico, Albuquerque, NM, 2School of Medicine, Trinity College, Dublin, Ireland, 3University of New Mexico, Occupational Therapy Graduate Program, Albuquerque, NM, 4Young Patients' Autoimmune Research & Empowerment Alliance, San Diego, CA

    Background/Purpose: Fatigue is one of the most prevalent and disabling symptom reported by people with systemic sclerosis (SSc). No fatigue-specific programs exist for people with…
  • Abstract Number: 0393 • ACR Convergence 2022

    Are We Meeting Patients’ Treatment Goals with Guideline-Based Therapy for Psoriatic Arthritis?

    Christeen Samuel1, Laura Prichett1, Thomas Grader-Beck1, Uzma Haque1, John Miller1, Suzanne Grieb2 and Ana-Maria Orbai3, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Johns Hopkins University School of Medicine and School of Public Health, Baltimore, MD, 3Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, MD

    Background/Purpose: Treatment success from the patients' perspective has not been defined in psoriatic arthritis (PsA). The objective was to determine prevalence and associations of patient-reported…
  • Abstract Number: 0793 • ACR Convergence 2022

    Autonomic Nervous System Dysfunction Common Among Patients with Long COVID: An Exploratory Evaluation

    Norman Gaylis1, Odense DeLaRosa1, Nayak Polissar2, Nirnaya Miljacic2 and Andrew Holman3, 1Arthritis & Rheumatic Disease Specialties, Aventura, FL, 2Mountain Whisper Light, Seattle, WA, 3Inmedix Inc, Seattle, WA

    Background/Purpose: Up to 70% of the 236 million people who have been diagnosed with SARS-CoV-2 develop post-COVID symptoms. (1) This has been defined by the…
  • Abstract Number: 0847 • ACR Convergence 2022

    Association of Frontal Plane Trunk Motion During Gait with Abductor Strength, Fatigue, and Physical Activity in Women with Hip Osteoarthritis

    Sanghamitra Nayak1, Burcu Aydemir2, Chun-Hao Huang3 and Kharma Foucher1, 1University of Illinois at Chicago, Chicago, IL, 2Northwestern University, Chicago, IL, 3Northeastern University, Boston, MA

    Background/Purpose: We have previously reported that fatigue and hip abductor weakness are associated with reduced physical activity (PA) in women with hip osteoarthritis (OA). We…
  • Abstract Number: 0971 • ACR Convergence 2022

    Development of a Theory-based Educational Intervention for Fatigue in Systemic Lupus Erythematosus (SLE) Using Human-centered Design Methodology

    Shanthini Kasturi1, Stephanie Tate2, Thomas Farrar3, Lisa Mandl4, Amy LeClair1, Faye Chiu5, Monique Gore-Massy6, Iris Navarro-Millan7 and Sara Folta8, 1Tufts Medical Center, Boston, MA, 2Tufts University School of Medicine, Boston, MA, 3Tufts University School of Medicine, Portland, 4Hospital for Special Surgery, New York, NY, 5N/A, New York, NY, 6Covid-19 GRA, West Orange, NJ, 7Weill Cornell Medicine, New York, NY, 8Tufts University, Boston, MA

    Background/Purpose: Fatigue is a top concern of individuals with SLE and is a leading cause of work impairment and disability in this population. Although fatigue…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 16
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology